Premarket movers: LQDA settlement, BLK earnings, ACN-Workday program

LQDA reported a global settlement resolving all pending litigation with United Therapeutics, ensuring continued commercialization of YUTREPIA in PAH. The alert also cites BLK earnings; a Schedule 13D filing for BORR; ACN's launch of a Forward Deployed Engineering Program with Workday and investor-day updates; and a GME insider purchase. Reported premarket moves: LQDA +45%, BLK +5%, BORR +4.5%, ACN +4% and GME +2%.